Zydus Cadila has received final USFDA approval to market aspirin and extended release dipyridamole capsules, which is used to prevent excessive blood clotting and reduce the risk of strokes. The company will market the drug in the strengths of 25mg/ 200mg and the same will manufactured at its formulations manufacturing facility in Ahmedabad.
Company Profile : Cadila Healthcare Ltd
Leave a Reply